Teva, Intel to develop wearable technology for Huntington’s disease

Reuters, 15 September 2016
Author: Natalie Grover and Steven Scheer
“Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable technology platform to track the progression of disease in patients with Huntington’s, a fatal degenerative disorder. The inherited condition causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline in motor control, cognition and mental stability. Patients will use a smartphone and wear a smartwatch equipped with sensing technology that will continuously measure functioning and movement. The data from the devices will then be wirelessly streamed to a cloud-based platform that will translate it into scores to assess motor symptom severity.”
Find article here.